[Therapy of rectal carcinoma: oncologically adequate surgery is crucial].
The surgeon plays a major role in rectal cancer treatment concerning local recurrence and long-time survival. Thus, the rate of locally recurrent disease ranges from 4 to 55%. This state-of-the-art article points out the latest findings of surgical therapy, such as the total mesorectal excision, the limits of sphincter-preserving resection, the minimally invasive procedures and others, and reveals their impact on the patients outcome. Hence, oncologically adequate surgery allows to reduce the rate of local recurrence to 5 to 10% and to reach a 5-year survival rate of 70 to 80%.
Maurer
C A
CA
Klinik für Viszerale und Transplantationschirurgie, Inselspital, Bern.
Goekenjan
M
M
Krähenbühl
L
L
Büchler
M W
MW
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D008297:Male; D008866:Microsurgery / Q000379:methods; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D012004:Rectal Neoplasms / Q000401:mortality / Q000601:surgery*; D012007:Rectum / Q000601:surgery*; D013514:Surgical Procedures, Operative / Q000379:methods; D013528:Surgical Staplers; D015996:Survival Rate; D013537:Sutures